What is the current Price Target for the Eliem Therapeutics Inc stock?

The average Eliem Therapeutics Inc target price is $9.69. This is 382.09% higher than the current stock price. The highest price target is 422.39%, the lowest is 251.74%. 6 Analysts have issued a price target Eliem Therapeutics Inc 2026 .

How high will the Eliem Therapeutics Inc stock rise?

No reliable answer can be given as to how high the Eliem Therapeutics Inc stock will rise. The performance of stocks, including the Eliem Therapeutics Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Eliem Therapeutics Inc stock today?

The performance of Eliem Therapeutics Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Eliem Therapeutics Inc stock fall?

The decline in Eliem Therapeutics Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Eliem Therapeutics Inc Forecast, price target & analysts

$2.01

1.47% yesterday

Nasdaq, Sep 16, 10:02 pm CET

ISIN

US28658R1068

Symbol

CLYM

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Eliem Therapeutics Inc Target price 2025 - Analyst rating & recommendation

Eliem Therapeutics Inc Classifications & Recommendation:

Buy

90%

Hold

10%

Eliem Therapeutics Inc Price Target

Target Price	$9.69
Price	$2.01
Potential	382.09% register free of charge
Number of Estimates	6

	6 Analysts have issued a price target Eliem Therapeutics Inc 2026 . The average Eliem Therapeutics Inc target price is $9.69. This is 382.09% register free of charge higher than the current stock price. The highest price target is $10.50 422.39% register free of charge , the lowest is $7.07 251.74% register free of charge .
	A rating was issued by 10 analysts: 9 Analysts recommend Eliem Therapeutics Inc to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Eliem Therapeutics Inc stock has an average upside potential 2026 of 382.09% register free of charge . Most analysts recommend the Eliem Therapeutics Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-1.53	-0.76
	17.69%	50.33%
P/E		negative

6 Analysts have issued a Eliem Therapeutics Inc forecast for earnings per share. The average Eliem Therapeutics Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-1.53	17.69%
2025	$-0.76 50.33% Unlock
2026	$-0.76 0.00% Unlock
2027	$-0.98 28.95% Unlock

Current	-2.91	27.35%
2025	-2.65 9.03% Unlock
2026	-2.65 0.00% Unlock
2027	-2.05 22.64% Unlock

Eliem Therapeutics Inc...

Current Eliem Therapeutics Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Baird	Locked ➜ Locked	Locked	Aug 15 2025
Oppenheimer	Locked ➜ Locked	Locked	Jun 06 2025

Analyst Rating	Date
Locked Baird: Locked ➜ Locked	Aug 15 2025
Locked Oppenheimer: Locked ➜ Locked	Jun 06 2025

Discover more stocks with a high price target

Novo Nordisk 42.02%

Adyen 41.69%

BioNTech SE - ADR 40.27%

Deutsche Telekom 31.88%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now